210 results found.
                  
Orthopedic Sales in Line with Seasonal Expectations for 1Q19
By Mike Evers The first quarter of 2019 brought modest growth to the orthopedic market, as expected seasonal softness and more competition in digital surgery platforms slowed sales for some of the largest players. The 25 companies listed herein had combined total orthopedic sales of $8....
Integra LifeSciences Reports 1Q19 Orthopedic Revenue of $22.7MM, +0.2% vs. 1Q18
Integra LifeSciences reports 1Q19 orthopedic revenue of USD $22.7MM, +0.2% vs. 1Q18.
Orthopedic Industry Revenue Reaches $51 Billion in 2018
By Mike Evers Download Your Copies
Revenue Review: 4Q18 and Full Year 2018 Performance Highlights for Public Companies
By Mike Evers Below you’ll find a summary of the major 4Q18 and full year 2018 developments for publicly-traded orthopedic companies. Exhibits 1 and 2 show 4Q18 and full year performance, respectively.  Companies continue to refine their strategies to improve sales mix ...
Integra LifeSciences Reports 4Q18 Orthopedic Revenue of $25.4MM, -8.1% vs. 4Q17
Integra LifeSciences reports 4Q18 orthopedic revenue of USD $25.4MM, -8.1% vs. 4Q17, with
Integra LifeSciences Launches Panta 2 TTC Arthrodesis Nail
Integra LifeSciences introduced the Panta® 2 TTC Arthrodesis Nail for tibio-talo-calcaneal fusion. 
Integra LifeSciences Launches Titan Reverse Shoulder System-S
Integra LifeSciences commenced full market launch of the Integra® Titan™ Reverse Shoulder System-S, featurin...
Integra Enters Agreement to Develop a Short Stem and Stemless Shoulder System
Integra LifeSciences entered into a license and development agreement with Consortium of Focused Orthopedists for a s...
Revenue Review: 3Q18 Performance Highlights and 2018 Projections for Public Companies, Continued
By Mike Evers In the exhibits below, we've added nine companies to round out our revenue review for 3Q18. As noted in last month's 
First Procedures with Integra's XT Revision Total Ankle
Integra LifeSciences launched the Integra® XT Revision Total Ankle Replacement system.
3Q18 and 9 Month 2018 Performance Highlights for Public Companies
By Mike Evers Our recap highlights 3Q18 developments and ORTHOWORLD's projection of 2018 full-year revenue for the first publicly traded orthopaedic companies to report. Exhibits 1 and 2 below show year over year company performance for 3Q18 and nine months ending September 30, 2018...
SeaSpine Reports 3Q18 Revenue of $35.8MM, +12.9% vs. 3Q17
SeaSpine picks up momentum, posts 3Q18 revenue of US $35.8MM, +12.9% vs. 3Q17.
Integra LifeSciences Reports 3Q18 Revenue
Integra LifeSciences reports 3Q18 results; ORTHOWORLD estimates orthopaedic revenue of $22.7M, -0.8% vs. 3Q17.
SeaSpine Prices $50MM Public Offering of Stock
SeaSpine closed its underwritten public offering of 3,250,000 shares of its common stock for US $15.50/share, for gross proceeds of ~$50.4MM.
Joint Reconstruction Expected to Continue with Steady Growth
By Carolyn LaWell Joint reconstruction accounts for 37% of the global orthopaedic industry. We estimate that joint reconstruction product revenue surpassed $18 billion in 2017, an increase of $560.3 million or 3.2% vs. 2016. These numbers were published in
SeaSpine 2Q18 Revenue +7% vs. 2Q17
SeaSpine announced 2Q18 revenue of US $36.4MM, +6.5% vs. 2Q17, and 1H18 revenue of $69.6MM, +5.3% vs. 1H17. Thi...
Integra LifeSciences Reports 2Q18 Revenue
ORTHOWORLD estimates Integra LifeSciences’ 2Q18 orthopaedic revenue at US $30.4MM, -0.6% vs. 2Q17, and 1H18 revenue of $5...
Integra LifeSciences Reports 1Q18 Orthopaedic Revenue
ORTHOWORLD estimates Integra LifeSciences’ 1Q18 orthopaedic revenue at US $24.8M, -4.8% from 1Q17.
Integra LifeSciences Posts 4Q17, 2017 Revenue
ORTHOWORLD estimates Integra LifeSciences’ 4Q17 orthopaedic revenue at US $27.42MM, +7.3% from 4Q16, and 2017
Extremities and Sports Medicine Products Serve a Growing Surgeon Focus
By Julie A. Vetalice Per results of AAOS’ last Orthopaedic Practice in the United States survey, a growing number of surgeons focus on specialties of extremities and sports medicine (or as we call it, Arthroscopy/Soft Tissue Repair). This year, for the first time at the A...
First Surgery with Exactech Vantage Mobile Bearing Total Ankle
Exactech announced successful completion of the first surgery using the Vantage® Total Ankle Mobile Beari...
Integra LifeSciences Posts 3Q17 Revenue
ORTHOWORLD estimates Integra LifeSciences’ 3Q17 orthopaedic revenue at US $26.2MM, +4.8% from 3Q16, and year-to-date
Integra Enrollment in Cadence Total Ankle Postmarket Study
Integra LifeSciences implanted the first Cadence® Total Ankle as part of a non-randomized, prospective, multi-...
Integra LifeSciences 2Q17 Orthopaedic Revenue
ORTHOWORLD estimates Integra LifeSciences’ 2Q17 orthopaedic revenue at US $37.3MM, +34.1% from 2Q16, and 1H17 revenue of
Integra LifeSciences to Distribute aap Implantate's LOQTEQ Distal Radius System
Integra LifeSciences signed an agreement with aap Implantate to distribute the LOQTEQ®
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group